BioNTech SE (FRA:22UA)
Germany · Delayed Price · Currency is EUR 76.20
-0.10 (-0.13%)
Jun 3, 2026, 5:29 PM CET
BioNTech SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,687 | 3,055 | 2,892 | 3,924 | 17,311 | 18,977 | |
Revenue Growth (YoY) | 4.82% | 5.63% | -26.31% | -77.33% | -8.78% | 3834.63% |
Cost of Revenue | 629.4 | 641.8 | 541.3 | 599.8 | 2,995 | 2,912 |
Gross Profit | 2,058 | 2,413 | 2,350 | 3,324 | 14,316 | 16,065 |
Selling, General & Admin | 654.6 | 624.4 | 599 | 557.7 | 541.2 | 327.2 |
Research & Development | 2,136 | 2,105 | 2,254 | 1,783 | 1,537 | 949.2 |
Other Operating Expenses | 1,102 | 1,088 | 811.5 | 293 | 410 | 103.4 |
Operating Income | -1,548 | -1,405 | -1,314 | 690.4 | 12,643 | 15,284 |
Interest Income | 422.4 | 423.9 | 664 | 519.6 | 330.3 | 67.7 |
Interest Expense | -47.6 | -69.8 | -27.4 | -23.9 | -18.9 | -305.1 |
Total Non-Operating Income (Expense) | 374.8 | 354.1 | 636.6 | 495.7 | 311.4 | -237.4 |
Pretax Income | -1,174 | -1,051 | -677.7 | 1,186 | 12,954 | 15,046 |
Provision for Income Taxes | 78.7 | 85.3 | -12.4 | 255.8 | 3,520 | 4,754 |
Net Income | -1,252 | -1,136 | -665.3 | 930.3 | 9,434 | 10,293 |
Net Income to Common | -1,252 | -1,136 | -665.3 | 930.3 | 9,434 | 10,293 |
Net Income Growth | - | - | - | -90.14% | -8.34% | 67613.82% |
Shares Outstanding (Basic) | 247 | 242 | 240 | 241 | 243 | 244 |
Shares Outstanding (Diluted) | 247 | 242 | 240 | 243 | 250 | 260 |
Shares Change (YoY) | 3.18% | 0.54% | -0.95% | -2.84% | -3.81% | 4.51% |
EPS (Basic) | -5.07 | -4.70 | -2.77 | 3.87 | 38.78 | 42.18 |
EPS (Diluted) | -5.07 | -4.70 | -2.77 | 3.83 | 37.77 | 39.63 |
EPS Growth | - | - | - | -89.86% | -4.69% | 65950.00% |
Shares Outstanding | 252.88 | 251.33 | 239.97 | 237.73 | 243.22 | 242.52 |
Free Cash Flow | 632.7 | 280.9 | -78.8 | 5,122 | 13,248 | 762.2 |
Free Cash Flow Growth | 125.24% | - | - | -61.34% | 1638.15% | - |
Free Cash Flow Per Share | 2.56 | 1.16 | -0.33 | 21.10 | 53.04 | 2.93 |
Gross Margin | 76.58% | 78.99% | 81.28% | 84.71% | 82.70% | 84.66% |
Operating Margin | -57.62% | -45.99% | -45.45% | 17.59% | 73.03% | 80.54% |
Profit Margin | -46.60% | -37.19% | -23.01% | 23.71% | 54.50% | 54.24% |
FCF Margin | 23.55% | 9.20% | -2.73% | 130.53% | 76.53% | 4.02% |
EBITDA | -1,087 | -1,022 | -1,016 | 873.8 | 12,766 | 15,359 |
EBITDA Margin | -40.45% | -33.46% | -35.15% | 22.27% | 73.75% | 80.94% |
EBIT | -1,548 | -1,405 | -1,314 | 690.4 | 12,643 | 15,284 |
EBIT Margin | -57.62% | -45.99% | -45.45% | 17.59% | 73.03% | 80.54% |
Effective Tax Rate | -6.71% | -8.12% | 1.83% | 21.57% | 27.17% | 31.59% |